For research use only. We do not sell to patients.
Monalizumab
CAS No. : 1228763-95-8
Biological Activity：Monalizumab is a first-in-class immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC)[2].
Research Area：Cancer|Inflammation/Immunology
Targets：IFNAR|Checkpoint Kinase (Chk)
Related Small Molecules:AX-024;Cirsilineol;Ginsenoside F3;VER-00158411;Deucravacitinib;BML-277;CHK1-IN-3;GDC-0425;PF 477736;SCH900776;SAR-020106;TYK2-IN-12;Anti-Mouse IFNAR1 Antibody;GSK2245035;Prexasertib;CHK1-IN-2;CP-28888;Delmitide;Chk1-IN-6;SM-276001;2′,3′-cGAMP sodium;ODN 2216;CCT241533 dihydrochloride;MRT00033659;CHK1 inhibitor;ODN 1585
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
